HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Houlihan, D. J. Articles by Zubenko, G. S. Search for Related Content PubMed Articles by Houlihan, D. J. Articles by Zubenko, G. S.

A Naturalistic Study of Trazodone in the Treatment of Behavioral Complications of Dementia

Altered serotonin transmission has been associated with behavioral complications of degenerative dementia. This study examined whether trazodone, a serotonergic antidepressant, may be useful in treating behavioral syndromes associated with dementia. Twenty-two dementia patients with behavioral problems were treated with trazodone (mean daily dose 172 ± 107 mg; mean duration 20 days). Seventy of cognitive impairment and behavioral symptoms were rated using the Mini-Mental State Examination (MMSE), the Global Assessment Scale, the Hamilton Rating Scale for Depression, and the Brief Psychiatric Rating Scale. A global assessment of improvement was made by chart review. Mean scores, with the exception of the MMSE, improved modestly but significantly between admission and discharge. Chart review of target symptoms revealed that 82% of the patients showed moderate-to-marked improvement on discharge, with most able to return to their preadmission residence. Trazodone was generally well tolerated except for occasional mild sedation effects. Results suggest that trazodone may be a useful alternative to neuroleptics or benzodiazepines in treating behavior problems in some demented patients.

This article has been cited by other articles:

				O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, and S. T. DeKosky Patterns of Change in the Treatment of Psychiatric Symptoms in Patients With Probable Alzheimer's Disease From 1983 to 2000 J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 67 - 73. [Abstract] [Full Text] [PDF]

				D. L. Sukonick, B. G. Pollock, R. A. Sweet, B. H. Mulsant, J. Rosen, W. E. Klunk, K. B. Kastango, S. T. DeKosky, and R. E. Ferrell The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease Arch Neurol, September 1, 2001; 58(9): 1425 - 1428. [Abstract] [Full Text] [PDF]

				K. L. Lanctôt, N. Herrmann, and P. Mazzotta Role of Serotonin in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, February 1, 2001; 13(1): 5 - 21. [Abstract] [Full Text]

				F. H. Ramadan, B. J. Naughton, and A. G. Bassanelli Treatment of Verbal Agitation with a Selective Serotonin Reuptake Inhibitor J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 56 - 59. [Abstract] [PDF]

				P. N. Tariot, L. S. Schneider, and I. R. Katz Anticonvulsant and Other Non-neuroleptic Treatment of Agitation in Dementia J Geriatr Psychiatry Neurol, October 1, 1995; 8(1): S28 - S39. [Abstract] [PDF]